Evidence map›Paper›PMID 27083399›Full record

ArticleBone2016

Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.

Marco Masci, Min Wang, Laurianne Imbert, Aileen M Barnes, Lyudmila Spevak, Lyudmila Lukashova, Yihe Huang, Yan Ma, Joan C Marini, Christina M Jacobsen and 2 more

Abstract read
In one paragraph

Article in Bone, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. An Update on Animal Models of Osteogenesis Imperfecta.Calcified tissue international · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Bone quality changes associated with aging and disease: a review.Annals of the New York Academy of Sciences · 2017
    Review
  17. Review
  18. Review
  19. Vibrational spectroscopic techniques to assess bone quality.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Marco MasciWeill Cornell Medical College, New York, NY, United States. Electronic address: mam2147@med.cornell.edu.
Min WangMineralized Tissues Laboratory, Hospital for Special Surgery, New York, NY, United States. Electronic address: 19650877@qq.com.
Laurianne ImbertMineralized Tissues Laboratory, Hospital for Special Surgery, New York, NY, United States. Electronic address: ImbertL@HSS.edu.
Aileen M BarnesNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States. Electronic address: Barnesai@mail.Nih.gov.
Lyudmila SpevakMineralized Tissues Laboratory, Hospital for Special Surgery, New York, NY, United States. Electronic address: SpevakM@HSS.edu.
Lyudmila LukashovaMineralized Tissues Laboratory, Hospital for Special Surgery, New York, NY, United States. Electronic address: Lukashoval@HSS.edu.
Yihe HuangDepartment of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States. Electronic address: Yihehuang@email.gwu.edu.
Yan MaDepartment of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States. Electronic address: yanma@email.gwu.edu.
Joan C MariniNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States. Electronic address: oidoc@helix.nih.gov.
Christina M JacobsenDivision of Endocrinology and Genetics, Children's Hospital Boston, Boston, MA, United States; Department of Pediatrics, Harvard Medical School, Boston, MA, United States. Electronic address: Christina.jacobsen@childrens.harvard.edu.
Matthew L WarmanOrthopaedic Research Laboratories, Department of Orthopaedic Surgery, Boston Children's Hospital, Boston, MA, United States. Electronic address: Matthew.Warman@childrens.harvard.edu.
Adele L BoskeyWeill Cornell Medical College, New York, NY, United States; Mineralized Tissues Laboratory, Hospital for Special Surgery, New York, NY, United States. Electronic address: Boskeya@HSS.edu.
Hospital for Special Surgery · USBoston Children's Hospital · USMilken Institute · USNational Institutes of Health · USCornell University · US

Funding

Heritable Disorders of Connective TisueZIAHD008830 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MARINI, JOAN C · 2009 to 2023
$9.2M
FT-IR MICROSCOPY OF MINERAL STRUCTURE IN OSTEOPOROSISR01AR041325 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI GOLDRING, MARY B · 1993 to 2017
$9.2M
TRABECULAR BONE ADAPTATION TO MECHANICAL LOADINGP30AR046121 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI BOSKEY, ADELE L · 1999 to 2010
$5.5M
Targeting the Lrp5 Pathway To Increase Bone Strength In Osteogenesis ImperfectaK08AR063813 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI JACOBSEN, CHRISTINA MARIE · 2013 to 2017
$706k
Does increasing bone mass also increase bone strength in mouse models of OI?R21AR062326 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI WARMAN, MATTHEW L · 2011 to 2012
$437k
NIAMS NIH HHS K08 AR063813NIAMS NIH HHS P30 AR046121NIAMS NIH HHS R01 AR041325NIAMS NIH HHS R21 AR062326
6 · The paper itself

Abstract

The Col1a2(+/G610C) knock-in mouse, models osteogenesis imperfecta in a large old order Amish family (OOA) with type IV OI, caused by a G-to-T transversion at nucleotide 2098, which alters the gly-610 codon in the triple-helical domain of the α2(I) chain of type I collagen. Mineral and matrix properties of the long bones and vertebrae of male Col1a2(+/G610C) and their wild-type controls (Col1a2(+/+)), were characterized to gain insight into the role of α2-chain collagen mutations in mineralization. Additionally, we examined the rescuability of the composition by sclerostin inhibition initiated by crossing Col1a2(+/G610C) with an LRP(+/A214V) high bone mass allele. At age 10-days, vertebrae and tibia showed few alterations by micro-CT or Fourier transform infrared imaging (FTIRI). At 2-months-of-age, Col1a2(+/G610C) tibias had 13% fewer secondary trabeculae than Col1a2(+/+), these were thinner (11%) and more widely spaced (20%) than those of Col1a2(+/+) mice. Vertebrae of Col1a2(+/G610C) mice at 2-months also had lower bone volume fraction (38%), trabecular number (13%), thickness (13%) and connectivity density (32%) compared to Col1(a2+/+). The cortical bone of Col1a2(+/G610C) tibias at 2-months had 3% higher tissue mineral density compared to Col1a2(+/+); Col1a2(+/G610C) vertebrae had lower cortical thickness (29%), bone area (37%) and polar moment of inertia (38%) relative to Col1a2(+/+). FTIRI analysis, which provides information on bone chemical composition at ~7μm-spatial resolution, showed tibias at 10-days did not differ between genotypes. Comparing identical bone types in Col1a2(+/G610C) to Col1a2(+/+) at 2-months-of-age, tibias showed higher mineral-to-matrix ratio in trabeculae (17%) and cortices (31%). and in vertebral cortices (28%). Collagen maturity was 42% higher at 10-days-of-age in Col1a2(+/G610C) vertebral trabeculae and in 2-month tibial cortices (12%), vertebral trabeculae (42%) and vertebral cortices (12%). Higher acid-phosphate substitution was noted in 10-day-old trabecular bone in vertebrae (31%) and in 2-month old trabecular bone in both tibia (31%) and vertebrae (4%). There was also a 16% lower carbonate-to-phosphate ratio in vertebral trabeculae and a correspondingly higher (22%) carbonate-to-phosphate ratio in 2month-old vertebral cortices. At age 3-months-of-age, male femurs with both a Col1a2(+/G610C) allele and a Lrp5 high bone mass allele (Lrp5+/A214V) showed an improvement in bone composition, presenting higher trabecular carbonate-to-phosphate ratio (18%) and lower trabecular and cortical acid-phosphate substitutions (8% and 18%, respectively). Together, these results indicate that mutant collagen α2(I) chain affects both bone quantity and composition, and the usefulness of this model for studies of potential OI therapies such as anti-sclerostin treatments.

Indexed as

Bone DensityAnimalsBody CompositionCancellous BoneCollagen Type ICortical BoneDisease Models, AnimalGenotypeLow Density Lipoprotein Receptor-Related Protein-5MaleMiceOsteogenesis ImperfectaSignal TransductionSpectroscopy, Fourier Transform InfraredX-Ray MicrotomographyCol1a2 protein, mouseCollagen Type ILow Density Lipoprotein Receptor-Related Protein-5Lrp5 protein, mouseFTIRIG610C mutationMicro-computed tomographyOld order Amish miceOsteogenesis imperfecta

Identifiers

PMID27083399
PMCPMC4862917
OpenAlexW2338193302

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.